Cleveland Diagnostics Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
114
- Latest Deal Type
-
Series E1
- Latest Deal Amount
-
$14.4M
- Investors
-
9
Cleveland Diagnostics General Information
Description
Developer of a blood-based cancer diagnostics platform designed for early disease detection. The company's technology measures structural differences in proteins to identify biomarkers from cancer cells, enabling healthcare providers to reduce unnecessary biopsies and differentiate between high-risk and low-risk patients.
Contact Information
Website
www.clevelanddx.comCorporate Office
- 3615 Superior Avenue
- Suite 4406A
- Cleveland, OH 44114
- United States
Corporate Office
- 3615 Superior Avenue
- Suite 4406A
- Cleveland, OH 44114
- United States
Cleveland Diagnostics Timeline
Cleveland Diagnostics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Later Stage VC (Series E1) | 20-Oct-2025 | $14.4M | Completed | Generating Revenue | ||
| 9. Later Stage VC (Series E) | 16-Jan-2024 | Completed | Generating Revenue | |||
| 8. Later Stage VC (Series D) | 22-Feb-2023 | Completed | Generating Revenue | |||
| 7. Later Stage VC (Series D) | 09-Feb-2021 | Completed | Generating Revenue | |||
| 6. Debt - PPP | 07-Apr-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC (Series C) | Completed | Generating Revenue | ||||
| 4. Early Stage VC | 12-Dec-2017 | Cancelled | Generating Revenue | |||
| 3. Early Stage VC (Series B) | 21-Nov-2016 | Completed | Generating Revenue | |||
| 2. Early Stage VC (Series A) | 11-Mar-2015 | $1.98M | $1.98M | Completed | Startup | |
| 1. Spin-Off | 06-Nov-2013 | Completed | Startup |
Cleveland Diagnostics Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E-1 | ||||||||
| Series E-2 | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | 1,459,271 | $0.000100 | 8% | $1.57 | $1.57 | 1x | $1.57 | 2.55% |
| Series A | 2,385,244 | $0.000100 | 8% | $0.83 | $0.83 | 1x | $0.83 | 4.17% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Cleveland Diagnostics Comparisons
Industry
Financing
Details
Cleveland Diagnostics Competitors (23)
One of Cleveland Diagnostics’s 23 competitors is Hain Lifescience, a Corporate Backed or Acquired company based in Nehren, Germany.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Hain Lifescience | Corporate Backed or Acquired | Nehren, Germany | ||||
| Foundation Medicine | Formerly VC-backed | Boston, MA | ||||
| Boreal Genomics | Formerly VC-backed | Vancouver, Canada | ||||
| Decipher Urologic Cancers | Formerly VC-backed | San Diego, CA | ||||
| Genalyte | Venture Capital-Backed | San Diego, CA |
Cleveland Diagnostics Patents
Cleveland Diagnostics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2026122608-A1 | Systems and methods for analyte assessment, regardless of competing binders | Pending | 04-Dec-2024 | ||
| AU-2022377268-A1 | Partitioning systems and methods for determining multiple types of cancers | Pending | 28-Oct-2021 | ||
| CA-3236536-A1 | Partitioning systems and methods for determining multiple types of cancers | Pending | 28-Oct-2021 | ||
| EP-4423506-A1 | Partitioning systems and methods for determining multiple types of cancers | Pending | 28-Oct-2021 | ||
| US-11796544-B1 | Partitioning systems and methods for determining multiple types of cancers | Active | 28-Oct-2021 | G01N33/57585 |
Cleveland Diagnostics Signals
Cleveland Diagnostics Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Serial Stage Venture Partners | Venture Capital | Minority | ||
| Shanghai Creation Investment Management | Venture Capital | Minority | ||
| Novo Holdings | Venture Capital | Minority | ||
| Nottingham Unlimited Ventures | Venture Capital | Minority | ||
| Cleveland Clinic Ventures | Corporate Venture Capital | Minority |
Cleveland Diagnostics FAQs
-
When was Cleveland Diagnostics founded?
Cleveland Diagnostics was founded in 2013.
-
Where is Cleveland Diagnostics headquartered?
Cleveland Diagnostics is headquartered in Cleveland, OH.
-
What is the size of Cleveland Diagnostics?
Cleveland Diagnostics has 114 total employees.
-
What industry is Cleveland Diagnostics in?
Cleveland Diagnostics’s primary industry is Diagnostic Equipment.
-
Is Cleveland Diagnostics a private or public company?
Cleveland Diagnostics is a Private company.
-
What is the current valuation of Cleveland Diagnostics?
The current valuation of Cleveland Diagnostics is .
-
What is Cleveland Diagnostics’s current revenue?
The current revenue for Cleveland Diagnostics is .
-
How much funding has Cleveland Diagnostics raised over time?
Cleveland Diagnostics has raised $126M.
-
Who are Cleveland Diagnostics’s investors?
Serial Stage Venture Partners, Shanghai Creation Investment Management, Novo Holdings, Nottingham Unlimited Ventures, and Cleveland Clinic Ventures are 5 of 9 investors who have invested in Cleveland Diagnostics.
-
Who are Cleveland Diagnostics’s competitors?
Hain Lifescience, Foundation Medicine, Boreal Genomics, Decipher Urologic Cancers, and Genalyte are some of the 23 competitors of Cleveland Diagnostics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process